Tilray, Inc. Contracts & Agreements

132 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Credit Agreement, dated February 21, 2025, by and among Aphria Diamond Inc., Canadian Imperial Bank of Commerce and the other parties thereto
Credit Agreements
Tilray, Inc.
Pharmaceuticals
2025
Promissory note in the amount of $23,791,657 payable by Aphria Diamond Inc
Note Agreements
Tilray, Inc.
Pharmaceuticals
2025
Fourth Amendment and Consent to Credit Agreement, dated as of October 30, 2024
Credit Agreements
Tilray, Inc.
Pharmaceuticals
MI
2024
Amended and Restated 2024 Form of Executive Retention Agreement
Retention Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Promissory note in the amount of $23,791,657 payable by Aphria Diamond Inc
Note Agreements
Tilray, Inc.
Pharmaceuticals
2024
Description of Securities of the Registrant
Tilray, Inc.
Pharmaceuticals
2024
2024 Form of Executive Retention Agreement
Retention Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Equity Distribution Agreement, dated as of May 17, 2024, by and among Tilray Brands, Inc. and TD Securities (USA) LLC and Jefferies LLC
Equity Distribution Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Fourth Amended and Restated Wholesale Cannabis Supply Agreement, dated as of January 5, 2024, by and between 1974568 Ontario Limited and Aphria Inc. (incorporated by reference to...
Supply Agreements
Tilray, Inc.
Pharmaceuticals
2024
Waiver to Credit Agreement, dated as of January 5, 2024, by and between Four Twenty Corporation, Bank of America, N.A., and the Guarantors and Lenders party thereto (incorporated...
Credit Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Promissory note in the amount of $26,134,500 payable by 1945689 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2024
Form of 2024 EBITDA Performance Award
Bonus & Incentive Agreements
Tilray, Inc.
Pharmaceuticals
2024
Third Amendment and Consent to Credit Agreement, dated as of March 29, 2024, by and among American Beverage Crafts Group, Inc. (formerly known as Four Twenty Corporation), Bank of...
Credit Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Amended and Restated Credit Agreement, dated as of March 14, 2024, by and among Aphria Diamond Inc., Aphria Inc., the Company, Bank of Montreal and the Guarantors and Lenders...
Credit Agreements
Tilray, Inc.
Pharmaceuticals
2024
Fourth Amended and Restated Wholesale Cannabis Supply Agreement, dated as of January 5, 2024, by and between 1974568 Ontario Limited and Aphria Inc
Supply Agreements
Tilray, Inc.
Pharmaceuticals
2024
Waiver to Credit Agreement, dated as of January 5, 2024, by and between Four Twenty Corporation, Bank of America, N.A., and the Guarantors and Lenders party thereto
Credit Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Promissory note in the amount of $8,057,622 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Form of 2023 EBITDA PSU Equity Incentive Award
Bonus & Incentive Agreements
Tilray, Inc.
Pharmaceuticals
2023
First Amendment to Securities and Asset Purchase Agreement, dated as of September 29, 2023
Purchase Agreements
Tilray, Inc.
Pharmaceuticals
2023
Second Amendment and Consent to Credit Agreement, dated as of September 29, 2023
Credit Agreements
Tilray, Inc.
Pharmaceuticals
DE
2023
Purchase Agreement, dated August 7, 2023, by and among Tilray,Anheuser-Busch Companies, LLC, Craft USA Holdings, LLC, Craft Brew Alliance, Inc. and Tilray Beverages, LLC
Purchase Agreements
Tilray, Inc.
Pharmaceuticals
WA
2023
Description of Securities of the Registrant
Tilray, Inc.
Pharmaceuticals
2023
Second Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and Computershare Trust Company of Canada
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
2023
Third Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and Computershare Trust Company of Canada
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
2023
Third Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and Computershare Trust Company of Canada
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
2023
Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and TSX Trust Company
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and TSX Trust Company
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and TSX Trust Company
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and TSX Trust Company
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Waiver and Amendment Agreement, dated as of June 1, 2023, by and between Tilray and HEXO
Waiver Agreements
Tilray, Inc.
Pharmaceuticals
2023
Arrangement Agreement Amendment, dated as of June 1, 2023, by and between Tilray and HEXO
Tilray, Inc.
Pharmaceuticals
2023
Underwriting Agreement, dated May 25, 2023, by and among Tilray Brands, Inc. and Jefferies LLC and BofA Securities, Inc., as representatives of the several underwriters named...
Underwriting Agreements
Tilray, Inc.
Pharmaceuticals
DC
2023
Indenture, dated May 31, 2023, between Tilray Brands, Inc. and Computershare Trust Company, N.A
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
DE
2023
First Supplemental Indenture, dated May 31, 2023, between Tilray Brands, Inc. and Computershare Trust Company, N.A
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
DE
2023
Share Lending Agreement, dated May 25, 2023, between Tilray Brands, Inc. and Jefferies Capital Services, LLC
Stock Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Promissory note in the amount of $9,264,249.68 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Promissory note in the amount of $6,648,304 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Arrangement Agreement, dated as of April 10, 2023, by and between Tilray and HEXO
Tilray, Inc.
Pharmaceuticals
DE
2023
Letter Agreement, dated as of April 10, 2023, by and between Tilray and HEXO
Tilray, Inc.
Pharmaceuticals
2023
Voting Agreement dated as of February 21, 2023, between Double Diamond Holdings Ltd. and Tilray Brands, Inc
Voting Agreements
Tilray, Inc.
Pharmaceuticals
DE
2023
Assignment and Assumption Agreement, dated September 1, 2022, between Double Diamond Holdings Ltd., and Tilray Brands, Inc
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
2023
Promissory note in the amount of $30,585,819.60 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Promissory note in the amount of $8,464,139.70 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Amended and Restated Credit Agreement, dated as of November 28, 2022, by and among 1974568 Ontario Limited, Aphria Inc., Tilray Brands, Inc., Bank of Montreal as agent and the...
Credit Agreements
Tilray, Inc.
Pharmaceuticals
2022
Form of Restricted Stock Unit Grant Notice (2022 HEXO EBITDA Award) under the Amended and Restated 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Tilray, Inc.
Pharmaceuticals
2022
Assignment and Assumption Agreement, dated June 30, 2022, between Double Diamond Holdings Ltd., and Tilray Brands, Inc
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
2022
Promissory note in the amount of $5,063,709.00 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2022
Description of Securities of the Registrant
Tilray, Inc.
Pharmaceuticals
2022
Employment Agreement by and between the Registrant and Mitchell Gendel, dated July 26, 2021
Employment Agreements
Tilray, Inc.
Pharmaceuticals
DE
2022
Amending Agreement to Amended and Restated Assignment and Assumption Agreement dated as of July 12, 2022, by and among the Company, HTI and HEXO
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
2022
Convertible Promissory Note due September 1, 2023, dated July 12, 2022, issued and owing by the Company to HTI
Note Agreements
Tilray, Inc.
Pharmaceuticals
2022
Amended and Restated Senior Secured Convertible Note due 2026, dated July 12, 2022, issued and owing by HEXO to the Company
Note Agreements
Tilray, Inc.
Pharmaceuticals
2022
Indenture dated as of May 27, 2021, by and between HEXO Corp. as issuer, and GLAS Trust Company LLC, as trustee
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
NY
2022
Amending Agreement to Transaction Agreement, dated as of June 14, 2022, by and among the Company, HT Investments MA LLC and HEXO
Investment Agreements
Tilray, Inc.
Pharmaceuticals
NY
2022
Amended and Restated Assignment and Assumption Agreement, dated as of June 14, 2022, by and among the Company, HT Investments MA LLC and HEXO
Investment Agreements
Tilray, Inc.
Pharmaceuticals
NY
2022
Form of Convertible Note due September 1, 2023, issued and owing by the Company to HTI
Note Agreements
Tilray, Inc.
Pharmaceuticals
DE
2022
Transaction Agreement, dated as of April 11, 2022, by and among the Company, HT Investments MA LLC and HEXO Corp
Investment Agreements
Tilray, Inc.
Pharmaceuticals
DE
2022
Assignment and Assumption Agreement, dated as of April 11, 2022, by and among the Company, HT Investments MA LLC and HEXO Corp
Investment Agreements
Tilray, Inc.
Pharmaceuticals
2022
Form of Amended and Restated Senior Secured Convertible Note due 2026, issued and owing by HEXO Corp. to the Company
Note Agreements
Tilray, Inc.
Pharmaceuticals
2022
Sales Agreement, dated as of March 3, 2022, by and between Tilray Brands, Inc. and Jefferies LLC and Canaccord Genuity LLC
Sales Agreements
Tilray, Inc.
Pharmaceuticals
NY
2022
Agreement Of Resignation, Appointment and Acceptance, dated as of January 27, 2022, by and among Tilray Brands, Inc., Glas Trust Company LLC and Computershare Trust Company, N.A
Trust Agreements
Tilray, Inc.
Pharmaceuticals
CO
2022
Agreement Of Resignation, Appointment and Acceptance, dated as of January 27, 2022, by and among Tilray Brands, Inc., Glas Trust Company LLC and Computershare Trust Company, N.A
Trust Agreements
Tilray, Inc.
Pharmaceuticals
2022
Agreement Of Resignation, Appointment and Acceptance, dated as of January 27, 2022, by and among Tilray Brands, Inc., Glas Trust Company LLC and Computershare Trust Company, N.A
Trust Agreements
Tilray, Inc.
Pharmaceuticals
CO
2022
Second Amendment to Credit Agreement with the Bank of Montreal, dated as of December 8, 2020, amended December 7, 2021
Credit Agreements
Tilray, Inc.
Pharmaceuticals
NY
2022
Employment Agreement by and between the Registrant and Irwin Simon, dated August 28, 2021
Employment Agreements
Tilray, Inc.
Pharmaceuticals
NY
2021
Employment Agreement by and between the Registrant and Denise Faltischek, dated August 28, 2021
Employment Agreements
Tilray, Inc.
Pharmaceuticals
DE
2021
Employment Agreement by and between the Registrant and Jim Meiers, dated August 28, 2021
Employment Agreements
Tilray, Inc.
Pharmaceuticals
DE
2021
Employment Agreement by and between the Registrant and Carl Merton, dated August 28, 2021
Employment Agreements
Tilray, Inc.
Pharmaceuticals
2021
Assignment and Assumption Agreement with Gotham Green Partners, LLC dated August 17, 2021
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
NY
2021
Assignment and Assumption Agreement with Parallax Master Fund, L.P. dated August 17, 2021
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
NY
2021
Assignment and Assumption Agreement with Pura Vida Master Fund, LTD. dated August 17, 2021
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
NY
2021
Indenture dated as of April 23, 2019, between Aphria Inc. and GLAS Trust Company LLC, relating to Aphria Inc.s 5.25% Convertible Senior Notes due 2024
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
NY
2021
First Supplemental Indenture dated as of April 30, 2021, among Aphria Inc., Tilray, Inc. and GLAS Trust Company LLC
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
NY
2021
Separation Agreement and Complete Release dated as of April 30, 2021, by and between Michael Kruteck and Tilray, Inc
Separation Agreements
Tilray, Inc.
Pharmaceuticals
2021
Separation Agreement and Complete Release dated as of April 29, 2021, by and between Jon Levin and Tilray, Inc
Separation Agreements
Tilray, Inc.
Pharmaceuticals
2021
Amendment No. 1 to Arrangement Agreement and Plan of Arrangement by and between Tilray and Aphria dated February 19, 2021
Tilray, Inc.
Pharmaceuticals
2021
Description of Securities of the Registrant
Tilray, Inc.
Pharmaceuticals
2021
Product and Trademark License Terms & Conditions, between Docklight LLC, and High Park Holdings Ltd, dated December 17, 2018
Trademark Agreements
Tilray, Inc.
Pharmaceuticals
WA
2021
First Amendment to Product and Trademark Licensing Agreement between Docklight Brands, Inc., successor to Docklight, LLC, and High Park Holdings Ltd, dated December 3, 2020
Trademark Agreements
Tilray, Inc.
Pharmaceuticals
2021
Separation Agreement and Complete Release by and between Tilray, Inc. and Andrew Pucher, dated February 8, 2021
Separation Agreements
Tilray, Inc.
Pharmaceuticals
2021
Arrangement Agreement by and between Tilray and Aphria dated December 15, 2020
Tilray, Inc.
Pharmaceuticals
DE
2020
Support Agreements by and between Tilray and Aphria Support Shareholders dated December 15, 2020
Shareholders Agreements
Tilray, Inc.
Pharmaceuticals
2020
Support Agreements by and between Aphria and Tilray Support Shareholders dated December 15, 2020
Shareholders Agreements
Tilray, Inc.
Pharmaceuticals
2020
Retention Agreements by and between Tilray and each of Michael Kruteck and Jon Levin dated December 18, 2020
Retention Agreements
Tilray, Inc.
Pharmaceuticals
2020
Separation Agreement and Complete Release by and between Tilray, Inc. and Edward Wood Pastorius, Jr., dated October 21, 2020
Separation Agreements
Tilray, Inc.
Pharmaceuticals
2020
Form of Tilray Director and Officer Indemnification Agreement
Indemnification Agreements
Tilray, Inc.
Pharmaceuticals
DE
2020
First Amendment to loan facility letter agreement dated as of February 28, 2020 among Bridging Finance Inc, as agent for and on behalf of any of the funds managed or co-managed by...
Loan Agreements
Tilray, Inc.
Pharmaceuticals
2020
Employment Agreement by and between the Registrant and Kathryn Dickson, dated November 20, 2019
Employment Agreements
Tilray, Inc.
Pharmaceuticals
WA
2020
Form of Pre-Funded Warrant
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
NY
2020
Form of Warrant
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
NY
2020
Underwriting Agreement, dated March 13, 2020, by and between the Company and Canaccord Genuity LLC
Underwriting Agreements
Tilray, Inc.
Pharmaceuticals
NY
2020
Description of Securities of the Registrant
Tilray, Inc.
Pharmaceuticals
2020
Payment Agreement by and between the Registrant and ABG Intermediate Holdings to, LLC dated January 14, 2019
Tilray, Inc.
Pharmaceuticals
NY
2020
Amended and Restated Profit Participation Agreement by and between the Registrant and ABG Intermediate Holdings 2, LLC dated January 20, 2020
Participation Agreements
Tilray, Inc.
Pharmaceuticals
NY
2020
First Amendment to Payment Agreement by and between the Registrant and ABG Intermediate Holdings 2, LLC dated January 24, 2020
Tilray, Inc.
Pharmaceuticals
2020
Employment Agreement by and between the Registrant and Andrew Pucher, Jr. dated November 8, 2018
Employment Agreements
Tilray, Inc.
Pharmaceuticals
2020
Employment Agreement by and between the Registrant and Jon Levin, dated January 13, 2020
Employment Agreements
Tilray, Inc.
Pharmaceuticals
WA
2020
Employment Agreement by and between the Registrant and Michael Kruteck, dated January 20, 2020
Employment Agreements
Tilray, Inc.
Pharmaceuticals
WA
2020
Credit Agreement, dated as of February 28, 2020, between High Park Holdings, Ltd. and Bridging Finance Inc
Credit Agreements
Tilray, Inc.
Pharmaceuticals
2020
Guarantee by and among the Registrant and certain guarantors named therein and Bridging Finance Inc., dated February 28, 2020
Guaranty Agreements
Tilray, Inc.
Pharmaceuticals
2020
U.S. Pledge and Security Agreement, by and among the Registrant, Manitoba Harvest USA LLC and Bridging Finance Inc., dated February 28, 2020
Security Agreements
Tilray, Inc.
Pharmaceuticals
NY
2020
Canadian Security Agreement, by and among High Park Holdings, Ltd., each of the obligors named therein, and Bridging Finance Inc., dated February 28, 2020
Security Agreements
Tilray, Inc.
Pharmaceuticals
2020
Form of Support Agreement by and between Tilray, Privateer and each of the parties named in each agreement therein
Tilray, Inc.
Pharmaceuticals
DE
2019
Form of Stockholder Lock-Up Agreement
Tilray, Inc.
Pharmaceuticals
2019
Lock-Up Agreement by Privateer, dated September 9, 2019
Tilray, Inc.
Pharmaceuticals
2019
Sales Agreement, dated as of September 10, 2019, by and between Tilray and Cowen and Company, LLC
Sales Agreements
Tilray, Inc.
Pharmaceuticals
NY
2019
Agreement and Plan of Merger and Reorganization, dated September 9, 2019, by and among Tilray, Privateer, Merger Sub and Michael Blue, as the Stockholder Representative
Merger Agreements
Tilray, Inc.
Pharmaceuticals
DE
2019
Payment Agreement by and between the Registrant and ABG Intermediate Holdings 2, LLC dated January 14, 2019
Tilray, Inc.
Pharmaceuticals
NY
2019
Profit Participation Agreement by and between the Registrant and ABG Intermediate Holdings 2, LLC dated January 14, 2019
Participation Agreements
Tilray, Inc.
Pharmaceuticals
NY
2019
Amending Agreement by and among Tilray, Inc. 1197879 B.C. Ltd., FHF Holdings Ltd. and Compass Group Diversified Holdings, LLC dated February 27, 2019
Tilray, Inc.
Pharmaceuticals
2019
Arrangement Agreement among 1197879 B.C. LTD. and FHF Holdings LTD. and Tilray, Inc. and the Shareholder Representative and Each Other Shareholder Bound by this Agreement dated...
Shareholders Agreements
Tilray, Inc.
Pharmaceuticals
2019
Arrangement Agreement among Tilray, Inc. and High Park Gardens Inc. and Natura Natural Holdings Inc. dated January 21, 2019
Tilray, Inc.
Pharmaceuticals
2019
Indenture, dated October 10, 2018, between Tilray, Inc. and GLAS Trust Company LLC
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
NH
2018
Form of U.S. Underwriting Agreement
Underwriting Agreements
Tilray, Inc.
Pharmaceuticals
NY
2018
Form of Canadian Underwriting Agreement
Underwriting Agreements
Tilray, Inc.
Pharmaceuticals
2018
Amended and Restated 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Tilray, Inc.
Pharmaceuticals
DE
2018
Form of Stock Option Agreement, Notice of Exercise and Stock Option Grant Notice under the Amended and Restated 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Tilray, Inc.
Pharmaceuticals
2018
Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Tilray, Inc.
Pharmaceuticals
2018
Form of Indemnity Agreement by and between the Registrant and its directors and officers
Tilray, Inc.
Pharmaceuticals
DE
2018
Board Services Agreement by and between the Registrant and Michael Auerbach dated June 1, 2018
Services Agreements
Tilray, Inc.
Pharmaceuticals
DE
2018
Board Services Agreement by and between the Registrant and Rebekah Dopp dated June 1, 2018
Services Agreements
Tilray, Inc.
Pharmaceuticals
DE
2018
Board Services Agreement by and between the Registrant and Maryscott Greenwood dated May 29, 2018
Services Agreements
Tilray, Inc.
Pharmaceuticals
DE
2018
Board Services Agreement by and between the Registrant and Christine St.Clare dated June 1, 2018
Services Agreements
Tilray, Inc.
Pharmaceuticals
DE
2018
Investor Rights Agreement by and between Registrant and certain of its stockholders dated February 5, 2018
Investor Rights Agreements
Tilray, Inc.
Pharmaceuticals
WA
2018
Employment Agreement by and between the Registrant and Brendan Kennedy dated May 30, 2018
Employment Agreements
Tilray, Inc.
Pharmaceuticals
WA
2018
Employment Agreement by and between the Registrant and Mark Castaneda dated May 30, 2018
Employment Agreements
Tilray, Inc.
Pharmaceuticals
WA
2018
Employment Agreement by and between the Registrant and Edward Wood Pastorius, Jr. dated May 30, 2018
Employment Agreements
Tilray, Inc.
Pharmaceuticals
WA
2018
Credit Facility Agreement between Lafitte Ventures, Ltd. and Privateer Holdings, Inc., dated January 1, 2016
Credit Agreements
Tilray, Inc.
Pharmaceuticals
WA
2018
Clarification of Credit Facility Agreement between Lafitte Ventures, Ltd. and Privateer Holdings, Inc., dated March 5, 2018
Credit Agreements
Tilray, Inc.
Pharmaceuticals
2018
Construction Facility Agreement between Privateer Holdings, Inc. and Bouchard Ventures, Ltd., dated November 1, 2017
Facility Agreements
Tilray, Inc.
Pharmaceuticals
WA
2018
Corporate Services Terms and Conditions between the Registrant and Privateer Holdings, Inc., dated February 5, 2018
Tilray, Inc.
Pharmaceuticals
WA
2018
Trademark License Terms & Conditions between Docklight LLC and High Park Company, dated February 13, 2018
Trademark Agreements
Tilray, Inc.
Pharmaceuticals
WA
2018